- Home
- TMDX vs JBLU Comparison
TMDX vs JBLU Comparison
Compare TMDX & JBLU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMDX
- JBLU
- Stock Information
- Founded
- TMDX 1998
- JBLU 1998
- Country
- TMDX United States
- JBLU United States
- Employees
- TMDX N/A
- JBLU N/A
- Industry
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- JBLU Air Freight/Delivery Services
- Sector
- TMDX Health Care
- JBLU Consumer Discretionary
- Exchange
- TMDX Nasdaq
- JBLU Nasdaq
- Market Cap
- TMDX 2.3B
- JBLU 2.1B
- IPO Year
- TMDX 2019
- JBLU N/A
- Fundamental
- Price
- TMDX $111.50
- JBLU $4.88
- Analyst Decision
- TMDX Buy
- JBLU Sell
- Analyst Count
- TMDX 10
- JBLU 11
- Target Price
- TMDX $122.89
- JBLU $4.98
- AVG Volume (30 Days)
- TMDX 1.2M
- JBLU 29.7M
- Earning Date
- TMDX 05-08-2025
- JBLU 04-29-2025
- Dividend Yield
- TMDX N/A
- JBLU N/A
- EPS Growth
- TMDX N/A
- JBLU N/A
- EPS
- TMDX 1.41
- JBLU N/A
- Revenue
- TMDX $488,227,000.00
- JBLU $9,210,000,000.00
- Revenue This Year
- TMDX $25.33
- JBLU $3.42
- Revenue Next Year
- TMDX $20.53
- JBLU $6.62
- P/E Ratio
- TMDX $79.36
- JBLU N/A
- Revenue Growth
- TMDX 64.43
- JBLU N/A
- 52 Week Low
- TMDX $55.00
- JBLU $3.34
- 52 Week High
- TMDX $177.37
- JBLU $8.31
- Technical
- Relative Strength Index (RSI)
- TMDX 78.52
- JBLU 58.88
- Support Level
- TMDX $92.49
- JBLU $4.35
- Resistance Level
- TMDX $95.71
- JBLU $4.93
- Average True Range (ATR)
- TMDX 4.79
- JBLU 0.26
- MACD
- TMDX 0.81
- JBLU 0.16
- Stochastic Oscillator
- TMDX 71.36
- JBLU 96.27
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
About JBLU JetBlue Airways Corporation
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It served approximately 100 destinations in the United States, the Caribbean and Latin America, Canada, and England. The company currently operates Airbus A321, Airbus A320, Airbus A321neo, and Embraer E190 aircraft types. The operating segments of company are Domestic & Canada, Caribbean & Latin America and Atlantic. Majority of revenue is generated from Domestic & Canada segment.